Merrimack Pharma Launches MM-310 at AACR By: Benzinga via Benzinga April 21, 2016 at 08:06 AM EDT Merrimack Pharmaceuticals, Inc. (NASDAQ: MACK) today announced positive data from preclinical studies evaluating MM-310, an antibody ... Read More >>